Aevius Raises $22M to Advance Medical AI
Aevius raised $22M in funding led by Insight Partners to develop AI models that transform complex medical data into actionable clinical intelligence.

The big picture: Aevius, a clinical artificial intelligence company spun out of Mass General Brigham, has launched with $22 million in funding led by Insight Partners. The company aims to develop AI models that transform complex medical data into actionable clinical intelligence.
Why it matters:
- Fragmented Data: Despite heavy investment in digitizing patient records, much clinical information remains distributed across disparate systems and formats, hindering effective use in clinical decisions and analytics.
- Actionable Intelligence: Aevius seeks to address this by integrating diverse medical data sources into a continuously updated, multimodal representation of each patient’s history and health trajectory.
- Broad Applications: The platform is designed to support health systems, insurers, and life sciences companies in areas like predictive patient outcomes, disease progression monitoring, and clinical trial identification.
How it works:
- Multimodal Integration: Aevius develops AI systems that analyze structured, unstructured, and multimodal medical data across patients’ clinical histories.
- Patient Representation: The technology integrates these sources into a ‘multimodal patient representation,’ serving as a reusable foundation for multiple AI applications without requiring separate data processing for each task.
- Computable Medicine: Co-founder and CEO Rowland Pettit states the mission is to make medicine ‘computable,’ unlocking more knowledge from existing clinical records than currently possible.
The catch: The clinical AI market is highly competitive, with numerous companies vying to leverage medical data for improved healthcare outcomes. Aevius will need to demonstrate clear return on investment and seamless integration into existing, often complex, healthcare workflows to differentiate itself and gain widespread adoption, especially given the sensitive nature of patient data.
Key Facts
- Company: Aevius
- Amount: $22M
- Investor: Insight Partners (lead)
- Founders: Rowland Pettit, Ming Yang (Max) Lu, Faisal Mahmood, Long Phi Le
- Sector: Clinical AI
- Headquarters: Boston, US
AIPressRoom Weekly
Every round we reported this week, the people behind the companies, and the events coming up. One email, every Tuesday.